SLRN
Income statement / Annual
Last year (2023), Acelyrin, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Acelyrin, Inc.'s net income was -$381.64 M.
See Acelyrin, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$115,000.00
|
$0.00
|
$0.00
|
| Gross Profit |
-$115,000.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
| Research and Development Expenses |
$355.89 M
|
$230.63 M
|
$38.23 M
|
| General & Administrative Expenses |
$66.18 M
|
$24.05 M
|
$3.56 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$66.18 M
|
$24.05 M
|
$3.56 M
|
| Other Expenses |
$0.00
|
-$132,000.00
|
-$45,000.00
|
| Operating Expenses |
$422.06 M
|
$254.68 M
|
$41.79 M
|
| Cost And Expenses |
$422.06 M
|
$254.68 M
|
$41.79 M
|
| Interest Income |
$30.56 M
|
$4.17 M
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$115,000.00
|
$69,179.00
|
$41,794.00
|
| EBITDA |
-$381.53 M |
-$64.77 M |
-$41.84 M |
| EBITDA Ratio |
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$40.42 M
|
$4.41 M
|
-$45,000.00
|
| Income Before Tax |
-$381.64 M
|
-$250.46 M
|
-$41.84 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
-$4.17 M
|
-$41,794.00
|
| Net Income |
-$381.64 M
|
-$250.46 M
|
-$41.84 M
|
| Net Income Ratio |
0
|
0
|
0
|
| EPS |
-5.43 |
-12.25 |
-2.05 |
| EPS Diluted |
-5.43 |
-12.25 |
-2.05 |
| Weighted Average Shares Out |
$70.25 M
|
$20.44 M
|
$20.44 M
|
| Weighted Average Shares Out Diluted |
$70.25 M
|
$20.44 M
|
$20.44 M
|
| Link |
|
|
|
